Novo Nordisk ready to launch oral semaglutide in US in 2026, executive says-February 2024-www.financetom.com

Novo Nordisk ready to launch oral semaglutide in US in 2026, executive says

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Novo Nordisk ready to launch oral semaglutide in US in 2026, executive says

Sep 17, 2025 3:09 AM

COPENHAGEN, Sept 17 (Reuters) - Novo Nordisk

is prepared for a full-fledged launch of oral semaglutide in the

United States in 2026, the group's head of product and portfolio

strategy told Reuters on Wednesday.

Previous page： --Intel Looks to Sell Stake in Altera for Billions, CNBC Reports Next page： Autoliv Surges Despite Mixed Q3 Results: Chinese Market Mix Drags Performance

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Intel Looks to Sell Stake in Altera for Billions, CNBC Reports

Oct 18, 2024

10:24 AM EDT, 10/18/2024 (MT Newswires) -- Price: 22.75, Change: +0.31, Percent Change: +1.36 ...

Autoliv Surges Despite Mixed Q3 Results: Chinese Market Mix Drags Performance

Oct 18, 2024

Autoliv, Inc. ( ALV ) shares are trading higher on Friday. The company reported third-quarter adjusted earnings per share of $1.84, missing the analyst consensus of $1.95. Quarterly revenues of $2.56 billion topped the street view of $2.53 billion. In the third quarter, sales fell by 0.8% organically. The firm performed well in Europe and Asia (excluding China) due to...

American Express Third-Quarter Revenue Misses Estimates; Raises Full-Year Profit Outlook

Oct 18, 2024

10:21 AM EDT, 10/18/2024 (MT Newswires) -- American Express' ( AXP ) third-quarter results increased year on year but revenue fell short of market estimates, while the payments company lifted its full-year earnings outlook. The company posted adjusted earnings of $3.49 a share for the September quarter, up from $3.30 the year before and topping the Capital IQ-polled consensus of...

Bullfrog AI Prices Direct Offering, Private Placement for Gross Proceeds of $3.1 Million

Oct 18, 2024

10:19 AM EDT, 10/18/2024 (MT Newswires) -- Bullfrog AI Holdings ( BFRG ) said Friday it has signed an agreement to buy and sell a total of about 1.6 million of its common shares in a registered direct offering and common warrants to buy up to an equal amount of common shares at a combined purchase price of $2 apiece...